Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection

This document is a response to comments on the MolDX Local Coverage Determination (L38568) titled 'MolDX: Molecular Testing for Solid Organ Allograft Rejection' and does not itself specify clinical coverage criteria. It records the comment and notice periods and a title revision from 'Liquid Biopsies for Solid Organ Transplantation' to the current title, with an effective date of 2021-06-06. No specific indications, limitations, documentation requirements, or frequency limits are provided in the text supplied.